Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Protein Networks02:26

Protein Networks

4.4K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic phase variation in the gut microbiome enhances bacterial adaptation.

Cell host & microbe·2026
Same author

Cardiometabolic and Renal Outcomes in Semaglutide Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study.

Advances in therapy·2026
Same author

Long-term outcomes of autologous cell transplantation for patients with non-TAO autoimmune disease-related critical limb ischemia.

Cell transplantation·2026
Same author

The linkage between hemoglobin-to-red blood cell distribution width ratio and osteoarthritis: a study based on the national health and nutrition examination survey.

Expert review of hematology·2026
Same author

Critical assessment of intratumor and low-biomass microbiome using long-read sequencing.

bioRxiv : the preprint server for biology·2026
Same author

Enhancing Perovskite Solar Cell Performance via Engineering the Hole Transport Interface with Star-Shaped Nitrogen-Rich Material.

The journal of physical chemistry letters·2026

Related Experiment Video

Updated: Jan 3, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K

Efficient Gaussian sample specific network marker discovery and drug enrichment analysis validation.

Wenbin Liu1, Yugai Du2, Gang Fang3

  • 1Institute of Computational Science and Technology, Guangzhou University, Guangzhou, 510006, China; Department of Physics and Electronic information engineering, Wenzhou University, Wenzhou, 325000, Zhejiang, China.

Computational Biology and Chemistry
|November 22, 2019
PubMed
Summary

This study introduces a novel framework for identifying individual-specific gene markers, enhancing personalized medicine. The new method improves cancer subtyping and survival analysis compared to previous approaches.

Keywords:
CancerDrugGaussian distributionNetwork biomarkers

More Related Videos

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.5K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

842

Related Experiment Videos

Last Updated: Jan 3, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.5K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

842

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Personalized medicine requires identifying individual-specific gene markers to understand patient-specific genetic mechanisms.
  • Existing methods for identifying sample-specific markers may not fully capture the complexity of gene expression noise and population information.

Purpose of the Study:

  • To develop an efficient framework for identifying sample-specific gene markers.
  • To improve the accuracy of cancer subtyping and survival analysis using identified markers.
  • To explore the application of these markers in guiding drug selection for cancer subtypes.

Main Methods:

  • Transforming gene expression data into a likelihood matrix to reduce noise and incorporate population information.
  • Mapping significantly differential genes/gene pairs to a STRING network, assuming Gaussian distribution for control group likelihood.
  • Applying the framework to benchmark datasets for lung adenocarcinoma, kidney renal clear cell carcinoma, and uterine corpus endometrial carcinoma.

Main Results:

  • The proposed framework outperforms the previous sample-specific network (SSN) method in subtyping and survival analysis.
  • Identified disease gene markers provide insights into underlying mechanisms of cancer subtypes.
  • Enriched drug sets based on subtype markers suggest potential for targeted drug selection.

Conclusions:

  • The developed framework is effective for identifying sample-specific gene markers.
  • This approach enhances personalized medicine by improving cancer subtyping and survival prediction.
  • The findings offer a pathway for selecting appropriate drugs for individual cancer subtypes.